Skip to main content

Arazlo Disease Interactions

There are 2 disease interactions with Arazlo (tazarotene topical).

Major

Retinoid/retinoid-like topical (applies to Arazlo) eczema

Major Potential Hazard, High plausibility.

Topical retinoids may cause severe irritation on eczematous skin. Therapy with topical retinoids should be avoided on abraded or eczematous skin.

References

  1. "Product Information. Retin-A (tretinoin)." Ortho McNeil Pharmaceutical PROD (2001):
  2. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc PROD (2001):
  3. "Product Information. Tazorac (tazarotene topical)." Allergan Inc PROD (2001):
Moderate

Retinoid/retinoid-like topical (applies to Arazlo) sunburn

Moderate Potential Hazard, High plausibility.

Retinoid-like products can cause extreme irritation when applied to sunburned skin. Patients with sunburn should be cautioned not to use retinoid-like acne products until fully recovered, and to avoid prolonged exposure to sunlight (including sunlamps) and use sunscreen/protective clothing during treatment with these products.

References

  1. Rosenbluth M "Adverse reaction to retin-A." J Am Dent Assoc 119 (1989): 346
  2. "Product Information. Retin-A (tretinoin)." Ortho McNeil Pharmaceutical PROD (2001):
  3. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc PROD (2001):
  4. "Product Information. Tazorac (tazarotene topical)." Allergan Inc PROD (2001):
View all 4 references

Arazlo drug interactions

There are 12 drug interactions with Arazlo (tazarotene topical).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer